Hemant Surgical Industries IPO GMP, Price, Dates & Allotment Details 2023
Introduction
The Hemant Surgical Industries IPO will open on May 24 and close on May 26, 2023. As per the DRHP filed with SEBI, the company intends to raise approximately ₹ 24.84 crores through this public offering, consisting of 27.60 lakhs shares with a face value of ₹ 10 each, which will be issued at a price of ₹ 85 to ₹ 90 per share.
Hemant Surgical Industries Limited (“the Company”)
Hemant Surgical Industries Limited was founded in 1989 and started its operations by importing and marketing medical disposables like meditapes, all over India from JMS Co Ltd. Japan. Later in the year 1999 company began its manufacturing operations with one Manufacturing unit and expanded its manufacturing and assembly operations to two additional units over the years.
Company manufacture, import, assemble and market a comprehensive portfolio of medical equipment and disposables.
Its product offerings cover a broad spectrum of equipment and disposables required for
- Renal Care,
- Cardiovascular disease
- Respiratory disease,
- Critical Care Radiology and
- Surgical disposables.
The company’s wide range of products includes some indigenously manufactured products along with some other products that are imported from countries like Japan, China France and Australia and are further processed in its assembly units. In addition, they are also providing services for the maintenance and running of dialysis centres.
Company strength
- They offer a diversified range of products.
- Existing well-established reputation and customer relationships
- Quality Assurance
- Experienced management team with industry expertise and a successful track record
- Stable financial performance with improved margins
Objects of the Issue,
The company proposes utilising the Fresh Issue’s net proceeds towards funding the following objects:
- Funding capital expenditure towards the installation of additional plant and machinery
- Funding to meet working capital requirements
- General Corporate Purpose
- Issue expenses
Financial Highlights (Restated)
| Particulars | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Net Worth | 2,360 | 1,298 | 837 |
| Total Assets | 6,491 | 5,438 | 4,290 |
| Total Borrowings | 712 | 938 | 1,446 |
| Total Revenue | 11,150 | 10,577 | 6,065 |
| Profit After Tax | 765 | 461 | 115 |
IPO details: Hemant Surgical Industries IPO
As per the DRHP filed with SEBI, 27.60 lakh shares will be offered as part of the fresh issue on the BSE SME segment. The face value of the shares is ₹ 10. The market maker would receive 144,000 shares of the offering. While Hem Securities Limited will be the lead manager for the IPO, Bigshare Services Pvt Ltd will be the registrar. It will be a book-built issue, so there will be a price band rather than a price point, and the actual issue price will be discovered by building the book.
| Issue Type | Book built issue IPO |
| IPO Price | ₹ 85 to ₹ 90 per share |
| Face Value | ₹ 10 per share |
| Market Lot | 1,600 shares |
| Issue Size | 2,760,000 shares (aggregating up to ₹ 24.83 crores) |
| Fresh Issue | 2,760,000 shares (aggregating up to ₹ [.] crores) |
| QIB Shares Offered | Not more than 50% of the net issue |
| NII (HNI) Shares Offered | Not less than 15% of the net issue |
| Retail Shares Offered | Not less than 35% of the net issue |
| Market Maker | Hem Finlease |
| Market maker portion | 144,000 shares (Added to NII Reservation) |
| Listing At | BSE SME |
| Company Promoters | Hanskumar Shamji Shah, Kaushik Hanskumar Shah, and Hemant Praful Shah |
GMP: Hemant Surgical Industries IPO
GMP, or grey market premium, is available on this page. The IPO GMP is updated on a day-to-day basis during the running period of the IPO, due to which the GMP rates fluctuate and stabilise after some time. GMP rates are not 100% guaranteed. Please click here for GMP details.
Tentative Dates: Hemant Surgical Industries IPO
The issue opens for subscription on May 24, 2023, and closes for subscription on May 26, 2023 (both days inclusive). The basis of allotment will be finalised on May 31, 2023, and the refunds will be initiated on June 1, 2023. In addition, the demat credits are expected to happen on June 2, 2023, and the stock will list on June 5, 2023, on the NSE SME. The UPI mandate confirmation cut-off time is 5:00 PM on the issue closing day (May 26, 2023).
| Opening Date | May 24, 2023 |
| Closing Date | May 26, 2023 |
| Basis of Allotment | May 31, 2023 |
| Initiation of Refunds | June 1, 2023 |
| A credit of shares to Demat A/c | June 2, 2023 |
| Listing Date | June 5, 2023 |
Lot Size
The lot size of the Hemant Surgical Industries IPO is 1,600 shares. A retail-individual investor can apply for up to 1 lot, i.e. 1,600 shares of ₹ 144,000.
| Applications | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Minimum) | 1 | 1,600 | ₹ 144,000 |
| Retail (Maximum) | 1 | 1,600 | ₹ 144,000 |
| HNI (Minimum) | 2 | 3,200 | ₹ 288,000 |
Promoters Holdings
| Pre-issue Shares Holdings | 100.00% |
| Post-issue Shares Holdings | 73.56% |
Miscellaneous Information
| Download Prospectus (PDF) | IPO DRHP |
| Company Contact Information | Hemant Surgical Industries Limited 502, 5th Floor, Ecstacy Business Park, Co-Op Society Limited, J.S.D. Road, Mulund (West), Mumbai – 400 080 Phone: 022-25915289/ 022- 259127 Email: cs@hemantsurgical.com Website: http://www.hemantsurgical.com/ |
| IPO Registrar | Bigshare Services Pvt Ltd Phone: +91-22-6263 8200 Email: ipo@bigshareonline.com Website: https://www.bigshareonline.com/ |
| IPO Lead Manager(s) | Hem Securities Limited |
FAQ’s
When will the Hemant Surgical Industries IPO allotment be available?
The finalisation of the basis of allotment for the Hemant Surgical Industries IPO will be done on May 31, 2023, and the allotted shares will be credited to your demat account by June 2, 2023. Check the Hemant Surgical Industries IPO allotment status.
When will Hemant Surgical Industries IPO list on exchanges?
The Hemant Surgical Industries IPO shares listing date is June 5, 2023.
How many Hemant Surgical Industries IPO Offer shares are reserved for HNIs and retail investors?
The investors’ portion for QIB is 50% of the Net Issue, NII (HNI) is 15% of the net issue, and Retail is 35%.
